Comparison of an Initial Risk-Based Testing Strategy vs Usual Testing in Stable Symptomatic Patients with Suspected Coronary Artery Disease: The PRECISE Randomized Clinical Trial
Pamela S. Douglas, Michael G. Nanna, Michelle D. Kelsey, Eric Yow, Daniel B. Mark, Manesh R. Patel, Campbell Rogers, James E. Udelson, Christopher B. Fordyce, Nick Curzen, Gianluca Pontone, Pál Maurovich-Horvat, Bernard De Bruyne, John P. Greenwood, Victor Marinescu, Jonathon Leipsic, Gregg W. Stone, Ori Ben-Yehuda, Colin Berry, Shea E. HoganBjorn Redfors, Ziad A. Ali, Robert A. Byrne, Christopher M. Kramer, Robert W. Yeh, Beth Martinez, Sarah Mullen, Whitney Huey, Kevin J. Anstrom, Hussein R. Al-Khalidi, Sreekanth Vemulapalli
Research output: Contribution to journal › Article › peer-review
22Scopus
citations
Fingerprint
Dive into the research topics of 'Comparison of an Initial Risk-Based Testing Strategy vs Usual Testing in Stable Symptomatic Patients with Suspected Coronary Artery Disease: The PRECISE Randomized Clinical Trial'. Together they form a unique fingerprint.